Clinical trial
Safety and Effectiveness of Remote Ischemic Conditioning With the autoRIC Prior to Elective Percutaneous Coronary Intervention (PCI) Study
NCT03318575 is registered in ClinicalTrials.gov with CellAegis US, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of Remote Ischemic Conditioning With the autoRIC Prior to Elective Percutaneous Coronary Intervention (PCI) Study
- Lead sponsor
- CellAegis US, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 30, 2018
- Completion date
- April 30, 2019
- Enrollment
- 500 (estimated)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
ischemia-reperfusion injury